Sitravatinib Uses, Dosage, Side Effects and more
Sitravatinib is under investigation in clinical trial NCT03680521 (Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma).
Trade Name | Sitravatinib |
Generic | Sitravatinib |
Sitravatinib Other Names | Sitravatinib |
Type | |
Formula | C33H29F2N5O4S |
Weight | Average: 629.68 Monoisotopic: 629.190831934 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |